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During the last 20 years, new and exciting roles for glial cells in brain development have
been described. Moreover, several recent studies implicated glial cells in the pathogene-
sis of neurodevelopmental disorders including Down syndrome, Fragile X syndrome, Rett
Syndrome, Autism Spectrum Disorders, and Fetal Alcohol Spectrum Disorders (FASD).
Abnormalities in glial cell development and proliferation and increased glial cell apoptosis
contribute to the adverse effects of ethanol on the developing brain and it is becoming
apparent that the effects of fetal alcohol are due, at least in part, to effects on glial cells
affecting their ability to modulate neuronal development and function. The three major
classes of glial cells, astrocytes, oligodendrocytes, and microglia as well as their precur-
sors are affected by ethanol during brain development. Alterations in glial cell functions
by ethanol dramatically affect neuronal development, survival, and function and ultimately
impair the development of the proper brain architecture and connectivity. For instance,
ethanol inhibits astrocyte-mediated neuritogenesis and oligodendrocyte development, sur-
vival and myelination; furthermore, ethanol induces microglia activation and oxidative stress
leading to the exacerbation of ethanol-induced neuronal cell death. This review article
describes the most significant recent findings pertaining the effects of ethanol on glial
cells and their significance in the pathophysiology of FASD and other neurodevelopmental
disorders.
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INTRODUCTION
Glial cells were first described by Rudolf Virchow in the middle
of the nineteenth century and had been considered until recently
as merely supportive and passive elements of the brain. In the last
20 years, there is accumulating evidence that rather than glial cells
being supporting players in brain function, they are co-stars with
neurons as new and exciting roles for them in brain development,
function, and disease have emerged (1).
Neurons and macroglia (which include astrocytes, oligoden-
drocytes, and ependymal cells) differentiate from common pre-
cursor cells, namely neuroepithelial cells that line the cerebral
ventricles and spinal canal during early brain development.
Some neuroepithelial cells directly differentiate into neurons,
although the majority of them are transformed into radial glial
cells, which, passing through the stages of intermediate cell-
type specific progenitor and precursor cells, generate neurons,
Abbreviations: ABCA1, ATP-binding cassette-A1; ABCG1, ATP-binding cassette
G1; ADNP, activity-dependent neuroprotective protein; ARSB, arylsulfatase B; ASD,
autism spectrum disorders; CNS, central nervous system; ECM, extracellular matrix;
FASD, fetal alcohol spectrum disorders; FMR1, fragile X mental retardation 1; IL1-
R1, interleukin1-receptor 1; iPSCs, induced pluripotent cells; MBP, myelin basic
protein; MeCP-2, methyl-CpG–binding protein 2; OPCs, oligodendrocyte precur-
sor cells; PAI-1, plasminogen activator inhibitor-1; PD, postnatal day; PKC, protein
kinase C; PLD, phospholipase D; SPARC, secreted protein acidic and rich in cys-
teine; SRF, serum response factor; TLR, toll-like receptor; tPA, tissue plasminogen
activator; uPA, urokinase plasminogen activator.
oligodendrocytes, and astrocytes (2). Cell-intrinsic and -extrinsic
cues regulate the differentiation of neural progenitors into each
cell type, enabling the formation of functional neural circuits.
Epigenetic mechanisms of chromatin remodeling appear to play a
role in the cell fate specification of precursor brain cells (3). The
mechanisms regulating the timing and the number of neurons
and glial cells generated from a common progenitor are not fully
understood. Microglia are the resident macrophages of the brain
and spinal cord. The current theory regarding microglia origins is
that they derive from immature erythromyeloid progenitors that
migrate from the yolk sac blood islands before the blood–brain
barrier starts developing (4, 5). Embryonic microglia proliferate
during late gestation and early postnatal development and colonize
the whole central nervous system (CNS) (4).
This review outlines the main roles played by astrocytes, oligo-
dendrocytes, and microglia, during physiological and pathological
brain development; furthermore, this review describes in detail
the effects of alcohol on glial cells during brain development
and highlights how these effects may contribute to the behavioral
and structural effects of alcohol as seen in fetal alcohol spectrum
disorders (FASD).
ASTROCYTES IN BRAIN DEVELOPMENT
Astrocytes, the most numerous cells in the mammalian brain, have
now been fully recognized as key mediators of brain development,
function, and plasticity. Astrocytes serve a particularly profound
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role in brain development by in large part coordinating neu-
ronal development through targeted release of trophic factors and
extracellular matrix (ECM) proteins leading neurite outgrowths,
allowing for neuronal survival, and controlling synapse formation
and function (6–15). Furthermore, astrocytes express numerous
receptors including receptors for neurotransmitters and neuro-
modulators that allow them to respond to cues deriving from
neurons (16). Thus, astrocytes play a major role in the formation
of neuronal circuits.
We demonstrated a new mechanism of astrocyte–neuron inter-
action by which the stimulation of astrocytes with the cholinergic
agonist carbachol leads to the activation of a complex signaling
involving phospholipase D (PLD), protein kinase C (PKC) ζ and
ε, p70S6 kinase, NF-kB pathway, and MAPK (17–24). This results
in an increase in neurite outgrowth of hippocampal neurons in
astrocyte–neuron co-cultures and hippocampal slices, an effect
mediated by M3 muscarinic receptors (8, 25).
Astrocytes secrete several molecules that are implicated in neu-
rite outgrowth and synaptogenesis. We characterized astrocyte
secretome by shotgun proteomic and found that most of the pro-
teins secreted by astrocytes are involved in neuronal development
and consist of ECM components as well as proteases, and pro-
tease inhibitors that modulate the levels of ECM by affecting the
rate of its degradation (26). ECM proteins are indeed involved
in astrocyte-modulated neuronal development processes, such as
neurite outgrowth and synaptogenesis.
In recent years, several astrocyte-secreted molecules involved
in the modulation of synaptogenesis have been identified includ-
ing ECM proteins thrombospondin, hevin, secreted protein acidic
and rich in cysteine (SPARC), membrane-anchored glypican, and
lipoproteins (7, 27–29). We have reported that the stimulation
of neurite outgrowth by carbachol-treated astrocytes is medi-
ated by increased expression of the ECM proteins fibronectin and
laminin in these cells and in the medium and by the upregulation
of plasminogen activator inhibitor-1 (PAI-1), an inhibitor of the
proteolytic degradation of the ECM (8).
Astrocytes also serve various roles in maintaining brain
integrity and health. Astrocytes during brain development play
a major role in the maturation, function, and maintenance of the
blood–brain barrier (30, 31). In addition, together with microglia,
they are responsible for immune function of the CNS contributing
to the regulation of the neuroinflammatory response (32).
ASTROCYTES AND NEURODEVELOPMENTAL DISORDERS
Recently astrocytes have been involved in the pathophysiology
of several neurodevelopmental diseases. Several studies identified
astrocyte dysfunction as a cause of altered development in sur-
rounding neurons; therefore, understanding how astrocyte func-
tions are altered in neurodevelopmental disorders is essential for
the development of more effective therapeutic strategies.
Between 2009 and 2010, four independent studies were pub-
lished indicating a role for astrocytes in four neurodevelopmental
disorders, namely Rett syndrome, Fragile X syndrome, Fetal Alco-
hol Spectrum Disorders (FASD), and Down syndrome (33–36).
These studies employed similar in vitro models of astrocyte–
neuron co-cultures to demonstrate that astrocytes derived from
methyl-CpG-binding protein 2 (MeCP2)-lacking mice (a model
for Rett Syndrome) (33), astrocytes derived form fragile X men-
tal retardation 1 (FMR1) knock-out mice (a model for Frag-
ile X syndrome) (36), astrocytes pre-treated with ethanol (a
model for FASD) (35), and astrocytes derived from human
Down syndrome fetuses (34) foster an altered neurite and den-
dritic spine development in co-cultured rodent hippocampal
neurons. A common finding of these studies is that, in these
neurodevelopmental disorders, astrocyte dysfunction has pro-
found effects on surrounding neurons. A follow-up study car-
ried out in the Rett syndrome animal model showed that re-
expression of MeCP2 in astrocytes improved locomotion, anxi-
ety and respiratory patterns, prolonged lifespan, restored normal
dendritic morphology, and increased the levels of the synap-
tic vesicle protein vGlut1 (37). Dendritic defects of FMR1-
deficient neurons are significantly rescued when these cells
are grown on a monolayer of wild-type rather than FMR1-
deficient astrocytes. FMR1-deficient astrocytes, on the other
hand, delay dendritic growth and the formation of excitatory
synapses (36).
The non-cell-autonomous effects of astrocytes derived from
Down syndrome fetuses on dendritic spines were attributed to
reduced expression of the ECM protein thrombospondin-1 (34),
which is involved in astrocyte-stimulated synapse formation (7).
A recent study carried out in astrocytes and neurons differenti-
ated from induced pluripotent cells (iPSCs) derived from Down
syndrome patients demonstrated that Down syndrome astro-
cytes reduce neurogenesis, induce cell death, and fail to pro-
mote maturation and synaptogenesis in Down syndrome neu-
rons. In addition, Down syndrome astrocytes display increased
glial fibrillary acidic protein (GFAP) and S100B expression and
nitric oxide generation, indicating that they are in a reactive
state (38). The antibiotic minocycline, which has been reported
to have anti-inflammatory and neuroprotective properties, par-
tially corrects the pathological phenotype of Down syndrome
astrocytes.
Reduced neuronal development has been also reported in
hippocampal pyramidal neurons co-cultured with astrocytes
pre-treated with developmental neurotoxicants, such as the
organophosphorus insecticide diazinon, its active metabolite dia-
zoxon, and manganese (39, 40). Alexander’s disease is a genetic
disease caused by gain-of-function point mutations in the GFAP
gene. Alexander’s disease is an astrogliopathy, a primary disease
of astrocytes. Astrocytes are the major producers of GFAP, and
Alexander disease astrocytes present Rosenthal fibers accumula-
tion and increased levels of GFAP. Alexander’s disease is character-
ized by macrocephaly, abnormal white matter, and developmental
delay (41, 42). The mechanism of astrocyte dysfunction is not fully
understood,but the presence of white matter injury suggests effects
on oligodendrocytes and myelination. Astrocyte and microglia
activation caused by prenatal infections has been associated with
reduced number of oligodendrocytes, altered myelination, and
schizophrenia (43, 44).
In conclusion, fast-growing evidence indicates that astrocytes
play a major role in neurodevelopmental disorders caused by both,
genetic mutations and environmental exposures. Thus, astrocytes
may be a new target for the development of therapeutic agents to
treat these diseases (45, 46).
Frontiers in Pediatrics | Child and Neurodevelopmental Psychiatry November 2014 | Volume 2 | Article 123 | 2
Guizzetti et al. Glia and FASD
OLIGODENDROCYTES IN BRAIN DEVELOPMENT
Central nervous system myelin is an extension of the plasma mem-
brane of oligodendrocytes wrapping multiple times around the
axon where it forms a compacted sheath. Myelin allows for the
process of saltatory conduction of action potentials propagated
between nodes of Ranvier increasing the speed and efficiency
of nerve conduction and is specific to vertebrates. Myelin, first
described by Ehrenberg in 1833, was initially viewed as a static
component surrounding the axons. It is now well established that
the myelination process involves complex and dynamic cell–cell
interactions (47, 48) that can be modified by functional experi-
ence (49, 50). In addition, there is evidence that oligodendrocytes
and myelin provide trophic support to axons and promote their
integrity and survival (51, 52).
Central nervous system myelination occurs late in brain devel-
opment: in humans, the majority of CNS myelination occurs
during the first two decades of life (53), in rodents, during the
first two postnatal months. There is now evidence that in both
humans and rodents, myelination continues throughout life (54,
55). Oligodendrocytes are the last cells to be generated during
development, although oligodendrocyte precursor cells (OPCs)
are produced much earlier in development (starting on E12.5 in
mice). OPCs are produced in restricted areas and subsequently
migrate and populate the entire brain where they later develop
into mature oligodendrocytes. Some OPCs are present in the
mature brain where they may be responsible for adult myelina-
tion (56). The myelination process is largely driven by intrinsic
genetic mechanisms, but increasing evidence indicates that a major
role is also played by experience-driven plasticity. Several extra-
cellular signals, intracellular pathways, and transcription factors
regulating oligodendrocyte differentiation and myelination have
been characterized (52).
OLIGODENDROCYTES AND NEURODEVELOPMENTAL DISORDERS
Several types of prenatal insults have been shown to later affect
myelination, indicating that effects on the generation or survival of
OPCs during fetal development are responsible for altered myelin
in the adult brain. Indeed, it has been reported that gestational
exposure to stresses, including hypoxia, restraint stress, opioids,
vitamin B12 deficiency, and methamphetamine decrease myeli-
nation in the offspring postnatal brain (57–61). Prenatal infec-
tions associated with astrocyte and microglia activation induce
myelin and oligodendrocytes abnormalities and may be linked to
schizophrenia (43, 44).
MICROGLIA IN BRAIN DEVELOPMENT
Microglia are resident CNS immune cells that represent approx-
imately 10% of the total brain cell population (62). Microglia
are of hematopoietic origin; their main function in the adult
brain is to monitor the environment and to respond to infec-
tion and injury. Microglia exist in two conformations: survey-
ing microglia, presenting a ramified morphology, and activated
microglia, which can assume an ameboid, rod, multinucleated,
or epithelioid morphology (62). Microglia respond to almost all
types of CNS insult by switching from a surveillance state to one of
the activated states that involves changes in cell morphology, gene
expression, and function (62). Activated microglia produce many
pro-inflammatory mediators, including cytokines, chemokines,
reactive oxygen species (ROS), and nitric oxide. Furthermore,
microglia can become phagocytic and contribute to the clear-
ance of pathogen infections and toxic cellular debris after injury.
While microglia activation is aimed at protecting neurons from
infections, it can also trigger extensive and damaging neuroinflam-
mation that contribute to the progression of neurodegenerative
diseases (63).
Microglia are present in the amoeboid morphology during
embryonic development and transition toward a ramified mor-
phology during early postnatal development in rodents. During
CNS development, microglia play a major role in the refinement
of brain wiring and synaptic circuits (64–66). Neuronal apopto-
sis and synaptic pruning are important physiological processes
occurring in the developing brain where more than the neces-
sary neurons and synapses are generated. In the immature brain,
amoeboid microglia have an active role in phagocytosis of apop-
totic neurons, promotion of programmed cell death (67, 68), and
pruning of synapses (69). Mechanisms inducing engulfment of
synaptic structures and synaptic pruning by microglia include
activity-dependent mechanisms (70), fractalkine signaling (69),
and modulation of complement protein release by developing
synapses (71).
MICROGLIA AND NEURODEVELOPMENTAL DISORDERS
Several lines of evidence implicate microglia in autistic spectrum
disorders (ASD) (72). Several markers of neuroinflammation have
been reported in the brain of ASD patients. Indeed, high levels of
cytokines, which are expressed in the brain by activated microglia
(73), are found in the brains of autistic patients (74, 75). Further-
more, microglial activation has also been demonstrated in several
brain regions of ASD patients (76–78).
In a mouse model of Rett syndrome, a genetic disease of
the ASD spectrum caused by mutations in the MeCP2 protein,
microglia display reduced phagocytic activity; the motor abnor-
malities present in MeCP2 knock-out animals are partially rescued
by replacing MeCP2 in microglia (79). MeCP2-null microglial
cells release glutamate, delay neuronal development, and trigger
neurotoxicity in hippocampal neurons (80).
Epidemiologic studies show that prenatal exposure to infec-
tions is associated with increased risk of adult schizophrenia
(81). Because microglia are the main player in neuroinflammatory
responses, microglia may be implicated in alterations in brain cir-
cuits during the development caused by prenatal infections, which
may be involved in schizophrenia (43, 44).
FETAL ALCOHOL SPECTRUM DISORDERS
FASD are a heterogeneous group of conditions defined as the
physical, behavioral, and learning impairments that occur in the
offspring of women who drank alcohol during pregnancy (82,
83). FASD include fetal alcohol syndrome (FAS), partial FAS
(pFAS); alcohol-related neurodevelopmental disorders (ARND),
and alcohol-related birth defects (ARBD) (84, 85). Neurobehav-
ioral deficits associated with heavy prenatal alcohol exposure
include reduced IQ and impairments in several neurodevelopmen-
tal domains such as attention, reaction time, visuospatial abilities,
www.frontiersin.org November 2014 | Volume 2 | Article 123 | 3
Guizzetti et al. Glia and FASD
executive functions, fine and gross motor skills, memory, language,
and social and adaptive functions (86).
Glia involvement in FASD is suggested by the fact that the brains
of individuals with FASD present with abnormal glial migration
(87) and hypoplasia of the corpus callosum and anterior commis-
sure, two areas originally formed by neuroglial cells (88). Further-
more, the finding that microencephaly is strongly associated with
ethanol exposure during the brain growth spurt (89), a period
characterized by rapid glial cell proliferation and maturation, also
suggests a potential effect of ethanol on the proliferation, growth,
and maturation of glia. In experimental models, the involvement
of glial cells in the developmental effects of ethanol has been recog-
nized for more than 20 years. Earlier findings pertaining to glia and
FASD have been summarized in an excellent review (90); there-
fore, the present review will focus mostly on research published
during the last 15 years.
ASTROCYTES AND FASD
ASTROCYTE PROLIFERATION IN FASD
Several early studies investigated the effects of ethanol on astro-
cyte proliferation. The incubation of primary astrocytes in culture
with ethanol inhibits astrocyte proliferation induced by serum, M3
muscarinic receptor stimulation, and IGF-1 (91–93). Subsequent
studies revealed selectivity in the signaling pathways affected by
ethanol. Muscarinic receptor-mediated activation of phospholi-
pase C, subsequent increase in intracellular calcium, and activa-
tion of novel PKCε and of mitogen-activated protein kinases are
relatively unaffected by ethanol (24, 94). On the other hand, PLD-
mediated formation of phosphatidic acid and sequential activation
of atypical PKCζ, p70S6 kinase, and of NF-κB are all strongly
inhibited by ethanol (17, 20, 22).
Phospholipase D-induced phosphatidic acid formation was
identified by two groups as the direct target of ethanol in the inhi-
bition of muscarinic receptor- and serum-stimulated signaling in
astrocytes (22, 95). Indeed, ethanol is a competitive substrate for
PLD leading to the formation of phosphatidylethanol instead of
the physiological second messenger phosphatidic acid (96). Phos-
phatidic acid activates a myriad of signaling molecules, including
RAF, mTOR, p70S6K, and Akt and is involved in several cellular
functions, including intracellular trafficking, survival, and prolif-
eration (97, 98) (Figure 1). Inhibition of astrocyte proliferation by
ethanol is consistent with the reduced number of glial cells found
following in vivo ethanol exposure (99, 100), and may contribute
to ethanol-induced microencephaly (89).
ASTROCYTES AND NEURONAL PLASTICITY IN FASD
Several paradigms of neuronal plasticity are altered by alcohol
exposure during brain development in animal models of FASD,
as recently summarized in an excellent review article (101). A
large body of evidence suggests that structural plasticity is highly
affected by in utero alcohol exposure. Indeed, specific cortical maps
are altered in FASD models (102–104). Furthermore, prenatal
and/or neonatal alcohol exposure reduces dendritic branching and
dendritic spine density in hippocampal and neocortical pyramidal
neurons (105–110).
The importance of astrocytes in ethanol-induced changes in
neuritogenesis is indicated by co-culture experiments. Medium
FIGURE 1 | Enzymatic reactions catalyzed by PLD. PLD is associated
with membrane receptors including G-protein coupled receptors (GPCR),
receptor tyrosine kinases, or integrins, which all activate PLD. Shown is
GPCR-coupled PLD, which, upon activation under physiological conditions,
hydrolyzes phosphatidylcholine (PC) to produce choline and phosphatidic
acid (PA), a lipid second messenger that binds and activates several
signaling molecules including RAF, Akt, mTOR, and p70S6K and stimulates
several cell functions including proliferation, cell trafficking, and cell survival.
The PLD signaling pathway is disrupted by ethanol, which competes with
water leading to the formation of phosphatidylethanol (PEth) at the
expenses of phosphatidic acid, therefore, inhibiting phosphatidic
acid-activated signaling and functions.
from ethanol-cultured astrocytes was shown to impair neuronal
survival and neuritogenesis of rhombencephalic serotoninergic
neurons in culture (111). Astrocytes have also been reported to
modulate the effect of ethanol on dendritic development with dif-
ferent outcomes depending on the time of ethanol exposure (112).
Further, neuritogenesis is inhibited in cortical neurons grown in
the presence of astrocytes prepared from rats prenatally exposed to
ethanol in comparison to neurons incubated with astrocytes from
unexposed animals (113).
Several factors released by astrocytes have been implicated in
the effects of ethanol on neuritogenesis. The active fragment of
the astrocyte-released activity-dependent neuroprotective protein
(ADNP) has been implicated in ethanol’s effects on axonal growth
in cerebellar neurons (114). Serum response factor (SRF) in astro-
cytes has also been suggested to play a role in the effects of ethanol
on neuritogenesis. Indeed, overexpression of SRF in astrocytes
restores ocular dominance plasticity in a ferret model of FASD
(115, 116).
We have reported on the important role of muscarinic receptors
in ethanol-induced impairment in neuritogenesis related to FASD.
Hippocampal neuron neuritogenesis stimulated by astrocyte mus-
carinic receptor is inhibited by physiologically relevant concen-
trations of ethanol in an astrocyte–neuron co-culture model in
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FIGURE 2 | (A–C) Ethanol-treated astrocytes inhibits hippocampal neuron
neurite outgrowth. Hippocampal neurons plated on top of ethanol-pre-treated
astrocytes (75 mM) display reduced neurite outgrowth. Shown are
representative fields (20×) of neurons incubated with control (A) and
ethanol-treated (B) astrocytes; insets show the same fields at a lower
magnification (10×). (C) Quantification of the length of the longest neurite
and of minor neurite in 60 cells per treatment was carried out using the
software Image J. ***p<0.001, Student’s t test. (D–F) Neonatal ethanol
exposure inhibits dendrite outgrowth in PD9 rats. Male rat pups were
intubated with 5 g/kg ethanol or were sham (control) intubated from PD4 to
PD9 and sacrificed on PD9. The brains were stained using the Golgi-Cox
procedure. Representative CA1 neurons in control (D) and ethanol-exposed
rats (E) are shown (10×); insets show the same fields at a lower
magnification (4×). Dendrite length was measured using the software
Neurolucida (F). ***p<0.001 by Student’s t test. (G–I) Neonatal ethanol
exposure reduces dendrite length in PD36 rats. Female rat pups were
intubated with 5 g/kg/day of ethanol or were sham (control) intubated from
PD4 to PD9 and sacrificed on PD36. Brains were stained using the Golgi-Cox
procedure. Shown are representative CA1 hippocampal neurons in control
(G) and ethanol-exposed rats (H) (10×); insets show the same fields at a
lower magnification (4×). Dendrite length was measured using the software
Neurolucida (I). **p<0.01, Student’s t test.
which the two cell types are not in direct contact, an effect
confirmed also in hippocampal slices (25, 35). In addition, in
the absence of muscarinic receptor stimulation, ethanol-treated
astrocytes displayed a reduced ability to foster neurite outgrowth
when hippocampal pyramidal neurons and astrocytes are in
direct contact (117) (Figures 2A–C). Reduced pyramidal neuron
development is also observed in the hippocampus of postnatal
day (PD) 9 and PD 36 rats exposed to ethanol between PD 4
and PD 9, a model of alcohol exposure mimicking the third
trimester of human exposure (Figures 2D–I), in agreement with
what reported by others in hippocampal and cortical pyramidal
neurons (106, 109).
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Ethanol inhibits astrocyte-mediated neurite outgrowth by pro-
foundly affecting astrocyte secretion leading to the generation of
an environment that is repressive of neuronal development. We
have characterized several mechanisms by which ethanol affects
astrocyte secretion:
(a) Ethanol reduces the release of neuritogenic ECM proteins
laminin and fibronectin stimulated by muscarinic receptors
in astrocytes (35), which may be due to the perturbation of
the secretory pathway induced by ethanol in astrocytes (118).
(b) Ethanol induces a dysregulation of the plasminogen activator
system, an important player in ECM proteolysis. Plasmino-
gen is converted to the active proteolytic enzyme plasmin
by two plasminogen activators: tissue plasminogen activa-
tor (tPA) and urokinase plasminogen activator (uPA), which
are regulated by plasminogen activator inhibitor-1 (PAI-1), a
member of the serine protease inhibitor superfamily. PAI-1
binds and inhibits plasminogen activators, thereby prevent-
ing the proteolytic activation of plasminogen to plasmin and
the degradation of the ECM (119). We observed that ethanol
inhibits the upregulation of PAI-1 induced by muscarinic
receptor activation, therefore, increasing the degradation of
EMC proteins laminin and fibronectin. The inhibitory effect
of ethanol is in part mediated by ethanol-induced inhibition
of the PLD signaling in astrocytes (Figure 1) (35).
(c) In addition, we found that ethanol increased the levels and
release of tPA in astrocytes (120). Tissue-PA is upregulated by
alcohol in the brain of animal models of both alcoholism and
FASD, where it reduces the levels of laminin and causes neu-
rodegeneration (121, 122). We found that the upregulation
of tPA by ethanol is mediated by the epigenetic mechanism
of DNA methylation. Indeed, ethanol inhibits DNMT activity
and DNA methylation in the promoter region of tPA, thereby
increasing tPA expression in astrocytes (120).
(d) Ethanol through the inhibition of arylsulfatase B (ARSB)
activity increases the levels of chondroitin-4-sulfate and of
the chondroitin sulfate proteoglycan neurocan, which are
inhibitors of neurite outgrowth, in astrocytes in vitro and after
neonatal alcohol exposure in vivo (117).
Together, the evidence discussed in this section underscores
the role played by astrocytes in neuronal structural plasticity dur-
ing brain development and outlines the novel and very important
mechanism by which ethanol affects neuronal plasticity through
alterations in astrocyte secretion.
ASTROCYTES, OXIDATIVE STRESS, AND FASD
Astrocytes are immunoresponsive cells. Several in vitro studies
reported that ethanol induces oxidative stress in astrocytes in cul-
ture. Indeed, ethanol stimulates the formation of ROS, depletes
glutathione, and upregulates cyclooxygenase 2 and inducible
nitric oxide synthase expression via NF-κB activation in astro-
cytes (123, 124).
Ethanol activates Toll-like receptor 4/interleukin 1 recep-
tor 1(TLR4/IL-1R1) signaling in astrocytes; inhibition of TLR4
and IL-1R1 abolishes ethanol-induced NF-κB and AP-1 acti-
vation, inducible nitric oxide synthase, and cyclooxygenase-2
upregulation indicating that these receptors mediate ethanol-
induced inflammatory events in astrocytes (125). On the other
hand, cortical neurons are more sensitive than astrocytes to
ethanol and undergo apoptotic cell death mediated by increased
ROS production and GSH depletion; attenuated neuronal cell
death and reduced GSH depletion was observed when neurons
are co-cultured with astrocytes (126, 127).
ASTROCYTES AND BRAIN LIPID HOMEOSTASIS IN FASD
The maintenance of optimal cholesterol levels is essential to
brain development. As in the periphery, cholesterol is circulated
in the brain associated with lipoproteins, which are produced
by astrocytes; astrocytes and microglia, but not neurons, also
express apolipoprotein E (apo E). Lipoproteins produced and
released by astrocytes are discoidal in shape and contain apo E,
phospholipids, and cholesterol, but lack in the core lipids (cho-
lesterol esters or triglycerides). In contrast, lipoproteins found
in the cerebrospinal fluid are round, contain a cholesterol ester
core, and are similar to plasma high-density lipoproteins (HDL)
(128, 129). An important mechanism of brain cholesterol clear-
ance involves cholesterol efflux from brain cells to astrocyte-
released lipoproteins, which exit the brain after passing from the
brain parenchyma into the cerebrospinal fluid and across the
blood–brain barrier (130–132).
We have been investigating the hypothesis that ethanol
increases lipoprotein release from astrocytes leading to increased
cholesterol clearance and reduced levels of cholesterol in the whole
brain (133). The transporter ABCA1 (ATP-binding cassette-A1) is
essential for the generation of nascent lipoproteins in astrocytes,
subsequent cholesterol efflux is mediated by ABCG1 and ABCG4
transporters and lead to the lipidation and remodeling of nascent,
lipid-poor lipoproteins (134–136).
We have shown that ethanol increases ABCA1 and ABCG1 lev-
els, induces cholesterol efflux, and reduces cholesterol levels in
primary rat astrocytes in culture (137). Interestingly, isotretinoin,
which causes developmental effects similar to ethanol, induces
ABCA1 and ABCG1 expression, increases cholesterol efflux, and
decreases cholesterol content in astrocytes similarly to ethanol
(137, 138), suggesting a common mechanism of teratogenesis
(133). These observations were also confirmed in in vivo FASD
models. Indeed, neonatal alcohol exposure increases cortical levels
of ABCA1 (137); furthermore, prenatal alcohol exposure upregu-
lates ABCA1 and ABCG1 and reduces the levels of cholesterol in
the neocortex of GD 21 female fetuses (139). Figure 3 shows a
proposed model of the interactions of astrocytes and neurons in
cholesterol homeostasis and the effects of ethanol.
ASTROCYTE DIFFERENTIATION IN FASD
Published literature support the notion that the survival of prog-
enitor cells and their differentiation into astrocytes is inhibited
by ethanol leading to an overall decreased astrocyte population,
which may strongly affect neuronal development and survival
given the trophic role played by astrocytes.
Ethanol reduces the survival of neural progenitors from human
embryonic stem cells and their differentiation into astrocytes
(140, 141). Furthermore, ethanol exposure during embryogene-
sis reduces the telencephalic radial glia progenitor pool and its
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FIGURE 3 | Model for interactions of astrocytes and neurons in
cholesterol clearance and dysregulation by ethanol. (A) Cholesterol is
produced by both astrocytes and neurons. Astrocytes produce and release
nascent, lipid-poor lipoproteins through the lipidation of apoE via the
membrane-bound ABCA1. In the brain parenchyma, nascent lipoproteins
stimulate cholesterol efflux through their interaction with ABCA1 and
ABCG1 in astrocytes and ABCG4 in neurons. Lipoprotein-associated
cholesterol exits the brain through the cerebrospinal fluid. (B) Ethanol
upregulates ABCA1 and ABCG1 in astrocytes, and increases the formation
of astrocyte lipoproteins, which extract more cholesterol from astrocytes
and neurons (pathways upregulated by ethanol are in red). Neurons are
sensitive to changes in cholesterol content and, upon protracted induction
of cholesterol efflux, decrease their cholesterol content and undergo cell
death. Chol, cholesterol.
differentiation into neurons and astrocytes (142). Ethanol inhibits
precursor cell proliferation and astrogliogenesis also in a rodent
neurosphere culture model (143).
OLIGODENDROCYTES AND FASD
Most of the earlier studies on the effects of fetal alcohol on
myelination and oligodendrocytes have been carried out between
the late 1970s and the early 1990s followed by a paucity of
papers emerging for more than a decade. However, the last few
years were characterized by a resurrected interest in the effects
of alcohol on myelination during brain development. This was
triggered by advancements in imaging techniques allowing for
better evaluation of white matter damage in FASD individuals.
Oligodendrocyte differentiation and myelination in humans
occur mostly after birth; however, myelination is affected by
in utero alcohol exposure indicating that fetal alcohol effects on
OPCs results in altered oligodendrocyte development and myeli-
nation. Indeed, imaging studies have found global white matter
reduction and white matter abnormalities in children and ado-
lescents with FASDs (144, 145). Myelination is affected in several
in vivo FASD models. In developing rat brains, exposure to ethanol
alters myelin ultrastructure and delays myelination (146–148). It
was more recently reported that myelin is disrupted and oligoden-
drocyte morphology is altered also in a third-trimester equivalent
sheep model of FASD (149).
While abnormalities and delays in the biochemical profile of
myelin (150–152) and in myelin protein synthesis were reported
following prenatal alcohol exposure in rats, more dramatic effects
were obtained after ethanol exposure during the third-trimester
equivalent (i.e., the first 10 PDs), when oligodendrocytes begin
maturation and myelination (148). Several studies report delayed
or reduced expression of oligodendrocyte proteins suggesting
delayed differentiation. Ethanol delays the expression of myelin
basic protein (MBP) and the maturation of oligodendrocytes
cultured from PD 1–2 rats prenatally exposed to ethanol (153).
Postnatal ethanol exposure reduces the levels of MBP and myelin-
associated glycoprotein also in the cerebellum of PD15 rats (154).
Direct exposure of oligodendrocytes in culture to ethanol con-
firms an inhibited expression of MPB (155). Recently, widespread
oligodendrocyte apoptosis has been reported in the white matter
regions of the fetal brain of monkeys exposed to high alcohol
levels during the equivalent of the third trimester of human
gestation (156).
Hypoplasia of the optic nerve is common in individuals with
FAS and may be responsible for their reduced visual function
(157). Several alterations in the optic nerve myelin have been
reported in animal models of FASD, including permanent reduc-
tion in myelin thickness, fewer myelinated axons, aberrant myelin
sheaths, and myelin acquisition, which may account for fetal
alcohol-induced hypoplasia of the optic nerve (147, 158–160).
Together, these studies clearly indicate that oligodendrocytes
development and survival are affected by fetal alcohol leading to
altered myelination, which may have a great impact on axonal
size and ability to effectively transmit action potentials. Further
research is required to fully understand the mechanisms involved
in the effects of prenatal ethanol on oligodendrocyte development
and myelination.
MICROGLIA AND FASD
Microglial cells can be directly activated by alcohol. Indeed,
ethanol, by activating TLR2 and TLR4 signaling in microglia,
triggers phagocytosis and production of ROS and cytokines, fac-
tors that contributes to inflammation and cortical neuron apop-
tosis (161, 162). Microglia play also a role in alcohol-induced
apoptosis of developing hypothalamic neurons. Indeed, ethanol
increases the release of inflammatory cytokines form microglia
and induces oxidative stress and decreases the intracellular lev-
els of cAMP and BDNF in hypothalamic neurons co-cultured
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FIGURE 4 | Representation of the main effects exerted by ethanol on astrocytes, oligodendrocytes, and microglia that may play a role in the
neuropathology of FASD.
with ethanol-treated microglia (163–165); Ethanol also induces
microglia cell death both in vitro and after neonatal alcohol
exposure in vivo, effects that are prevented by a PPRγ agonist
(166). The effects of alcohol on neuroinflammation processes
involving microglia activation in fetal, adolescent, and adult
brain are the topic of several recent review articles and book
chapters (167–170).
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Recent studies indicate the essential role glial cells play in the devel-
oping brain. For example, growth factors released by astrocytes
guide neuritogenesis and support neuronal survival, microglia
mediate synaptic pruning, and oligodendrocytes regulate axonal
size, function, and survival. In this way, the development of brain
circuits depends on glia–glia and glia–neuron interactions. In
addition, several mechanisms underlying many neurodegenera-
tive and neurodevelopmental diseases are non-cell-autonomous
and involve glia–neuron interactions (171).
In this review, we summarize published evidence that glia–
neuron interactions play an essential role also in the pathophys-
iology of FASD. Astrocytes, oligodendrocytes, and microglia are
all highly affected by in utero alcohol exposure as summarized in
Figure 4. The impact of alcohol exposure on the brain should
not be considered as the sum of the isolated action of ethanol
on neurons, astrocytes, oligodendrocytes, and microglia. Indeed,
it is clear that alcohol not only affects signaling pathways within
a cell type but also strongly alters the ability of glial types to send
information to neurons and vice versa, therefore, greatly disrupting
the synchronized series of events that lead to the correct develop-
ment of the brain and the proper formation of the brain circuit
architecture. Thus, it is imperative that novel therapeutic strategies
for the treatment or prevention of the neurodevelopmental effects
of ethanol target not only the functions of individual cell types but
also mechanisms of glia–glia and glia–neuron communications.
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